TOKYO -- The jockeying to acquire Fuji Soft has exposed a hole in Japanese tender offer regulations that has allowed Bain Capital to vie with fellow U.S.-based private equity firm KKR without going ...

Bain Capital entered a deal to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) from Mitsubishi Chemical Group for 510 ...

Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking ...

Bausch + Lomb's efforts to sell have so far been unsuccessful. Meanwhile, KKR is aggressively pursuing a deal for Fuji Soft.

Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eased approval process for new medicine ...